Willingness to pay for a hypothetical malaria vaccine in Brazil: a cross-sectional study and the implications: supplementary materials

These are peer-reviewed supplementary materials for the article 'Willingness to pay for a hypothetical malaria vaccine in Brazil: a cross-sectional study and the implications' published in the Journal of Comparative Effectiveness Research.
Previous knowledge about malariaInformation about malariaConference about context understandingOpinion researchClinical dataExclusive to interviewerAim: Malaria is an infection caused by protozoa of genus Plasmodium, considered the one associated with increasingly large outbreaks. Methods: A cross-sectional study was conducted with residents in the northern region of Brazil on the willingness to pay (WTP) for a hypothetical vaccine against malaria (effective protection of 80%). Results: Of 616 people interviewed, most interviewees were female (61%) and were employed (97%). The median individual maximum WTP for a hypothetical malaria vaccine was US$11.90 (BRL 50). Conclusion: The northern region of Brazil is one of the largest markets for a malaria vaccine due to its epidemiological relevance. Consequently, economic studies will be important to assist in the assessment of the potential price and value of new vaccines.